The frequency of mutations for PIK3CA, MUC16 and TTN was significantly higher in high risk glioma cases (TTN, 26% vs. 7%; MUC16, 16% vs. 8%; PIK3CA, 10% vs. 3%). This evidence concerns the gene TTN and glioma.